Cantourage Group SE (FRA:HIGH)

Market Cap	68.09M +70.1%
Revenue (ttm)	3.91M +78.0%
Net Income	126.46K +59.5%
EPS	n/a
Shares Out	n/a
PE Ratio	538.41
Forward PE	56.74
Dividend	n/a
Ex-Dividend Date	n/a

Volume	4
Open	5.20
Previous Close	4.82
Day's Range	5.06 - 5.20
52-Week Range	2.13 - 6.80
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 10, 2026

About Cantourage Group SE

Cantourage Group SE, a medical cannabis company, produces and distributes medical cannabis preparations and cannabis-based pharmaceuticals in Europe and internationally. The company offers cannabis dried flowers, extracts, dronabinol/tetrahydrocannabinol (THC), and cannabidiol (CBD) products. It exports its products to other European countries. The company distributes its products through pharmacies, wholesalers, and partners. Cantourage Group SE was founded in 2019 and is headquartered in Berlin, Germany.

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 2019
• Employees: 11
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: HIGH

Financial Performance

In 2025, Cantourage Group SE's revenue was 3.91 million, an increase of 77.97% compared to the previous year's 2.20 million. Earnings were 126,458, an increase of 59.48%.

Data Sources: S&P Global Market Intelligence and Twelve Data

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Twelve Data.

Last checked:

Oct 26, 2026

Data Sources Report a data error